These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2076835)

  • 1. Computerized tomography with longitudinal follow-up of brain atrophy in patients with Parkinson's disease.
    Kitani M; Kobayashi S; Yamaguchi S
    Gerontology; 1990; 36(5-6):361-8. PubMed ID: 2076835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's syndrome: cranial computed-tomography findings. Their dependence on sex and age.
    Grundl W; Ziegler R; Westphal KP; Hufnagl M; Szirtes J; Kornhuber HH
    Acta Med Hung; 1991; 48(3-4):127-36. PubMed ID: 1822851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relation between infratentorial brain atrophy and clinical symptoms in Parkinson's disease].
    Kitani M; Kobayashi S; Yamaguchi S; Tsunematsu T
    Rinsho Shinkeigaku; 1986 Aug; 26(8):777-82. PubMed ID: 3802669
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebral atrophy in Parkinson's disease--represented in CT.
    Becker H; Schneider E; Hacker H; Fischer PA
    Arch Psychiatr Nervenkr (1970); 1979 Jul; 227(1):81-8. PubMed ID: 496619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological correlates of brain atrophy in Parkinson's disease: a CT-scan study.
    Starkstein SE; Leiguarda R
    Mov Disord; 1993; 8(1):51-5. PubMed ID: 8419807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The course of brain atrophy in Parkinson's disease.
    Schneider E; Becker H; Fischer PA; Grau H; Jacobi P; Brinkmann R
    Arch Psychiatr Nervenkr (1970); 1979 Jul; 227(1):89-95. PubMed ID: 496620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain atrophy and cerebral infarction.
    Takeda S; Matsuzawa T; Yamaura H
    Tohoku J Exp Med; 1984 Dec; 144(4):361-7. PubMed ID: 6528334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations.
    Ibarretxe-Bilbao N; Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Bargallo N; Juanes S; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):650-7. PubMed ID: 19965847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network structure of brain atrophy in de novo Parkinson's disease.
    Zeighami Y; Ulla M; Iturria-Medina Y; Dadar M; Zhang Y; Larcher KM; Fonov V; Evans AC; Collins DL; Dagher A
    Elife; 2015 Sep; 4():. PubMed ID: 26344547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between arteriosclerosis and cerebral atrophy in Parkinson's disease.
    Schneider E; Fischer PA; Becker H; Hacker H; Pencz A; Jacobi P
    J Neurol; 1977 Dec; 217(1):11-6. PubMed ID: 75248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cranial computerized tomography useful in the diagnosis of multiple system atrophy?
    Wenning GK; Jäger R; Kendall B; Kingsley D; Daniel SE; Quinn NP
    Mov Disord; 1994 May; 9(3):333-6. PubMed ID: 8041375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of brain atrophy in Parkinson's disease. A CT scan study.
    Steiner I; Gomori JM; Melamed E
    Neuroradiology; 1985; 27(2):158-60. PubMed ID: 3990948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain atrophy in Parkinson's disease--cerebral and cerebellar atrophy].
    Kitani M; Kobayashi S; Yamaguchi S; Tsunematsu T
    Nihon Ronen Igakkai Zasshi; 1985 Jul; 22(4):354-9. PubMed ID: 4068331
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy.
    Perju-Dumbrava LD; Kovacs GG; Pirker S; Jellinger K; Hoffmann M; Asenbaum S; Pirker W
    Mov Disord; 2012 Jan; 27(1):65-71. PubMed ID: 22102521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
    Sapkota S; Gee M; Sabino J; Emery D; Camicioli R
    Mov Disord; 2014 Mar; 29(3):368-74. PubMed ID: 24395213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography brain changes in parkinsonian dementia.
    Inzelberg R; Treves T; Reider I; Gerlenter I; Korczyn AD
    Neuroradiology; 1987; 29(6):535-9. PubMed ID: 3431698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy.
    Sroka H; Elizan TS; Yahr MD; Burger A; Mendoza MR
    Arch Neurol; 1981 Jun; 38(6):339-42. PubMed ID: 7236060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.